Selective ALK inhibitor alectinib with potent antitumor activity in models of crizotinib resistance
Year: 2014
Type: article
Source: Cancer Letters
Authors: Tatsushi Kodama, Toshiyuki Tsukaguchi, Miyuki Yoshida, Osamu Kondoh, Hiroshi Sakamoto
Institution: Chugai Pharmaceutical Co., Ltd. (Japan)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2015137322
